phase 3

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Praxis plots path to FDA after phase 3 wins in essential tremor

The trials demonstrated the benefits of ulixacaltamide in essential tremor after a previously grim outlook from one study earlier this year.
Zoey Becker Oct 16, 2025 11:48am
heart money

Cytokinetics’ ph. 3 cardio win sends stock soaring

Sep 2, 2025 2:05pm
Cartoon of businessmen standing around a broken target

Spine BioPharma misses primary endpoint in back pain phase 3

Aug 1, 2025 10:24am
Whale swimming in ocean seen from above

Merck wades deeper into HIV PrEP waters with pair of trials

Jul 14, 2025 1:12pm
Goal disorientation and lack of vision

UPDATED: Taiho’s discontinues ph. 3 trial after DMD miss

Jul 8, 2025 10:17am
Make a delay and accumulation of outstanding tasks Full stop

FDA delays force Daré to shelve phase 3 plans: WSJ

Apr 17, 2025 3:03pm